Academic Journal
Clinical utility of chromosomal microarray analysis for genetic diagnosis in 708 cases of spontaneous abortion tissues.
| Τίτλος: | Clinical utility of chromosomal microarray analysis for genetic diagnosis in 708 cases of spontaneous abortion tissues. |
|---|---|
| Συγγραφείς: | Huang Y; Changzhi Medical College, Changzhi, Shanxi, 046000, China.; Changzhi Key Laboratory of Precision Prevention and Control of Birth Defects, Changzhi, Shanxi, 046011, China., An Q; Changzhi Medical College, Changzhi, Shanxi, 046000, China.; Changzhi Key Laboratory of Precision Prevention and Control of Birth Defects, Changzhi, Shanxi, 046011, China., Tao Y; Changzhi Key Laboratory of Precision Prevention and Control of Birth Defects, Changzhi, Shanxi, 046011, China., Liu G; Changzhi Medical College, Changzhi, Shanxi, 046000, China., Li X; Changzhi Medical College, Changzhi, Shanxi, 046000, China. lixiaoze520@126.com.; Changzhi Key Laboratory of Precision Prevention and Control of Birth Defects, Changzhi, Shanxi, 046011, China. lixiaoze520@126.com. |
| Πηγή: | BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2026 Aug 01; Vol. 26 (1). Date of Electronic Publication: 2026 Aug 01. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967799 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2393 (Electronic) Linking ISSN: 14712393 NLM ISO Abbreviation: BMC Pregnancy Childbirth Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: London : BioMed Central, [2001- |
| Ιατρικοί όροι (MeSH): | Abortion, Spontaneous*/genetics , Abortion, Spontaneous*/diagnosis , Microarray Analysis*/methods , Genetic Testing*/methods , Chromosome Aberrations*, Humans ; Female ; Pregnancy ; Retrospective Studies ; DNA Copy Number Variations ; Adult ; Gestational Age ; Maternal Age ; Aneuploidy |
| Περίληψη: | Objective: To evaluate the diagnostic yield, abnormality spectrum, and clinical interpretation value of chromosomal microarray analysis (CMA) in products of conception from pregnancy loss, and to explore the associations of maternal age and gestational age with different categories of chromosomal abnormalities. Methods: This study involved a retrospective cohort analysis of chorionic villus or fetal tissue samples obtained from patients with spontaneous abortion who visited our center between 2017 and 2025. Genomic DNA was extracted from all samples and subjected to genome-wide screening using CMA to detect chromosomal aneuploidies and copy number variations (CNVs). The pathogenicity of detected CNVs was evaluated according to the guidelines established by the American College of Medical Genetics and Genomics (ACMG). Furthermore, clinical characteristics such as maternal age were used as stratification variables to compare the chromosomal abnormality rates across different subgroups. Results: Of the 708 samples analyzed, 348 cases (49.15%) were found to have clinically significant chromosomal abnormalities, comprising 347 pathogenic and one likely pathogenic variants. In the 705 samples with successful testing results, there were 365 detected chromosomal abnormalities, yielding a detection rate of 51.77%. This finding highlights that chromosomal abnormalities constitute a major genetic etiology of spontaneous abortion. Furthermore, within the successfully tested cohort, numerical chromosomal abnormalities were the most prevalent type, identified in 287 cases (40.71%). This was followed by microdeletions in 37 cases (5.25%) and microduplications in 27 cases (3.83%). However, mosaicism, whole-genome uniparental disomy (UPD), and long contiguous stretches of homozygosity (LCSH) were rare, being detected in only four cases in total. Among the numerical anomalies, autosomal trisomy was the primary subtype, with trisomy 16 being the most frequently observed autosomal trisomy. Conclusion: Chromosomal microarray analysis plays a pivotal role in the etiological diagnosis of spontaneous abortion. As a high-resolution, high-throughput detection method, it enables genome-wide identification of CNVs, particularly submicroscopic deletions and duplications that are difficult to detect with conventional karyotyping. CMA showed a high testing success rate and provided clinically useful information for the genetic evaluation of products of conception. Its advantages include direct DNA-based analysis without the requirement for viable cell culture and the ability to detect submicroscopic CNVs that may be missed by conventional karyotyping. However, because this study did not include a direct comparison with conventional karyotyping, cost-effectiveness analysis, or systematic parental validation for all clinically relevant findings, the results should be interpreted as supporting the clinical utility of CMA rather than establishing it as a universal routine test for all pregnancy loss cases. (© 2026. The Author(s).) |
| Competing Interests: | Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Review Committee of Changzhi Maternal and Child Health Hospital (Approval No.CZSFYLL2025-008). Written informed consent was obtained from all participants. Consent for publication: All authors consent to the publication of this manuscript. Competing interests: The authors declare no competing interests. |
| References: | HGG Adv. 2026 Jan 15;7(1):100549. (PMID: 41267400) Genet Med. 2020 Feb;22(2):245-257. (PMID: 31690835) Hum Genet. 2022 May;141(5):1003-1012. (PMID: 34426854) Mol Cytogenet. 2024 Feb 18;17(1):4. (PMID: 38369498) Ultrasound Obstet Gynecol. 2020 Jan;55(1):96-104. (PMID: 31364215) Front Endocrinol (Lausanne). 2023 Oct 17;14:1218793. (PMID: 37916154) Sci Rep. 2025 Apr 19;15(1):13623. (PMID: 40253570) Am J Ther. 2024 Jul-Aug 01;31(4):e514-e516. (PMID: 38976542) Am J Obstet Gynecol. 2001 Jul;185(1):198-203. (PMID: 11483928) Front Genet. 2022 Mar 10;13:829728. (PMID: 35360839) Am J Obstet Gynecol. 2020 Sep;223(3):330-349. (PMID: 32105678) Genet Med. 2022 Feb;24(2):255-261. (PMID: 34906464) J Assist Reprod Genet. 2024 May;41(5):1285-1296. (PMID: 38668959) BMC Med Genomics. 2024 Jan 8;17(1):15. (PMID: 38191380) Cells. 2024 Dec 26;14(1):. (PMID: 39791709) Reprod Biomed Online. 2021 Jul;43(1):120-126. (PMID: 33926784) Sci Rep. 2024 Jan 25;14(1):2190. (PMID: 38273042) Eur J Med Res. 2025 Jul 1;30(1):528. (PMID: 40598400) Arthritis Res Ther. 2024 Oct 31;26(1):187. (PMID: 39482761) Front Genet. 2021 Sep 17;12:732419. (PMID: 34603391) World J Clin Cases. 2023 Apr 26;11(12):2811-2816. (PMID: 37214567) Mol Genet Genomic Med. 2023 Aug;11(8):e2181. (PMID: 37013615) Prenat Diagn. 2019 Feb;39(3):137-156. (PMID: 30734327) J Hum Genet. 2022 Nov;67(11):629-638. (PMID: 35896820) J Matern Fetal Neonatal Med. 2022 Nov;35(22):4404-4411. (PMID: 33228446) Cytogenet Genome Res. 2021;161(3-4):120-131. (PMID: 33975305) Front Genet. 2023 Jun 29;14:1203891. (PMID: 37470043) Front Genet. 2021 Apr 15;12:667697. (PMID: 33936179) Syst Biol Reprod Med. 2020 Dec;66(6):410-420. (PMID: 33059488) |
| Grant Information: | 202403021221345 Changzhi City Key Laboratory of Birth Defect Prevention and Control |
| Contributed Indexing: | Keywords: Chromosomal Microarray Analysis (CMA); Copy Number Variation (CNV); Genetic etiology; Spontaneous abortion |
| Entry Date(s): | Date Created: 20261030 Date Completed: 20261030 Latest Revision: 20261031 |
| Update Code: | 20261031 |
| PubMed Central ID: | PMC13717972 |
| DOI: | 10.1186/s12884-026-09716-8 |
| PMID: | 42958498 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1471-2393 |
|---|---|
| DOI: | 10.1186/s12884-026-09716-8 |